Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.

Professor David Kerr examines a massive meta-analysis raising questions about GLP-1 drugs and colorectal cancer risk in ...

Ethicist Art Caplan discusses a recent ethical consult on whether a suicide note should influence the decision whether to ...

A study of couples across four countries underscores partner inclusion, structured screening, and immediate referral to psycho-oncology to prevent maladaptive coping.

Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.

A new machine learning model built using a simple and interpretable approach predicts in-hospital death in patients with ...

An AI tool could flag patients at risk for osteoporosis or osteopenia by evaluating standard hip and pelvis x-rays, new ...

Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...

Results from Asia suggest chronic rhinosinusitis is associated with an increased risk for cancer, but whether these results ...

Patients with a particular histopathologic phenotype may respond less well to rituximab, but it is still unclear what factors ...

Skin disinfection with high-concentration chlorhexidine in isopropyl alcohol shows better effectiveness in reducing ...

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.